ASEAN’s soon-to-be device rules will have similar impact to EU’s MDD
This article was originally published in Clinica
The ASEAN medical device harmonization scheme is a major undertaking that will have a similar impact in the south-east Asian region as did the implementation of the medical device directives in the EU, said Abbott’s Philippe Auclair at the 4 June Informa conference on Asia-Pacific medical device regulations.
You may also be interested in...
With finite resources, the UK’s regulatory agency responsible for health care products is rapidly addressing COVID-19 medtech issues. But shifting its focus will cause delays elsewhere.
Non-CE-marked products on the EU market, virtual notified body audits, free standards and the Commission bid to pause the MDR. March has seen unprecedented developments as COVID-19 has railroaded through the sector decimating regulatory rules and plans.
Suppliers to the UK’s National Health Service from outside the EU could save up to 12% in costs for some equipment during COVID-19 emergency measures as the UK tries to increase supplies